Nov 20, 2020 · In patients with HCM, risk stratification and selection of patients for prophylactic ICD therapy continues to evolve, including novel risk markers and predictive scoring …

Assess the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy using the HCM Risk Calculator from the AHA. Try it our for free now.

Hypertrophic cardiomyopathy is a heterogeneous genetic disorder that increases the risk of sudden cardiac death (SCD). Implantable cardioverter-defibrillator (ICD) therapy is a safe and …

Dec 15, 2016 · There is a need for improved risk assessment to more accurately identify HCM patients at risk of SCD who may benefit from ICD implantation. Cardiac magnetic resonance …

Sep 8, 2020 · Timing of implantable cardioverter-defibrillator (ICD) therapy in hypertrophic cardiomyopathy (HCM). Top, Time interval from ICD implant to initial appropriate intervention …

Nov 20, 2020 · For HCM patients with cardiac arrest or sustained ventricular tachycardia (VT), single-chamber transvenous or subcutaneous implantable cardioverter-defibrillator (ICD) …

Through risk stratification strategies and prophylactic implantable cardioverter-defibrillator (ICD) indication, the mortality of patients with HCM has been reducing from 6 to <1% per year 1,4.

Dec 30, 2021 · The implantable cardioverter-defibrillator (ICD) is an established life-saving therapy in patients with hypertrophic cardiomyopathy (HCM) at high risk from sudden cardiac …

The epidemiology of SCD in patients is reviewed as well as the structural and genetic basis behind ventricular arrhythmias in HCM. The primary prevention of SCD with implantable …

Aug 10, 2023 · The main findings from this large, national registry of ICD use in patients with HCM were that (1) the number of ICDs used for primary prevention of SCD in patients with …